Erastin2
|
4(3H)-Quinazolinone, 2-[[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]methyl]-3-[4-(1-methylethoxy)[1,1'-biphenyl]-3-yl]-
|
1695533-44-8
|
Ozagrel
|
奥扎格雷
|
82571-53-7
|
Betrixaban
|
贝曲西班
|
330942-05-7
|
GSK2256098
|
GSK-2256098
|
1224887-10-8
|
Conteltinib
|
CONTELTINIB (CT-707)
|
1384860-29-0
|
BI-3663
|
BI 3663)
|
2341740-84-7
|
PROTAC FAK degrader 1
|
PROTAC FAK degrader 1
|
2301916-69-6
|
Ifebemtinib
|
1227948-82-4
|
1227948-82-4
|
Defactinib
|
地法替尼
|
1073154-85-4
|
BI-4464
|
BI 4464)
|
1227948-02-8
|
GSK215
|
GSK215
|
2743427-26-9
|
PND-1186
|
PND1186
|
1061353-68-1
|
FAPI-46
|
FAPI-46
|
2374782-04-2
|
FAPI-34
|
FAPI-34
|
2374782-07-5
|
OncoFAP
|
190327
|
2639365-69-6
|
FAP-2286
|
FAP2286
|
2581741-18-4
|
MB05032
|
2-氨基-5-异丁基-4-[5-膦酰基-2-呋喃基]噻唑
|
261365-11-1
|
ML-210
|
[4-[Bis(4-chlorophenyl)methyl]piperazin-1-yl]-(5-methyl-4-nitro-1,2-oxazol-3-yl)methanone
|
1360705-96-9
|
Linagliptin
|
利拉利汀
|
668270-12-0
|
Linagliptin-d4
|
利拉利汀杂质
|
2140263-92-7
|
FIN56
|
FIN56
|
1083162-61-1
|
UAMC-3203 hydrochloride
|
UAMC-3203 HYDROCHLORIDE
|
2271358-65-5
|
iFSP1
|
1-amino-3-(4-methylphenyl)pyrido[1,2-a]benzimidazole-2,4-dicarbonitrile
|
150651-39-1
|
Pioglitazone
|
匹格列酮
|
111025-46-8
|
Pioglitazone-d4
|
匹格列酮-D4
|
1134163-29-3
|
GPX4-IN-3
|
|
2761004-85-5
|
MMRi62
|
7-((2,3-二氯苯基)(吡啶-2-基氨基)甲基)喹啉-8-醇
|
352693-80-2
|
Erastin
|
ERASTIN
|
571203-78-6
|
Pifithrin-β hydrobromide
|
环状抑制剂-Α氢溴酸盐
|
511296-88-1
|
Deferasirox
|
地拉罗司
|
201530-41-8
|
Dopamine-d5 (hydrochloride)
|
盐酸多巴胺:(2 - (3 4-DIHYDROXYPHENYL)
|
2193106-55-5
|
NADPH tetrasodium salt
|
还原型辅酶Ⅱ四钠
|
2646-71-1
|
Eugenol-d3
|
Eugenol-d3
|
1335401-17-6
|
Alogliptin-d3
|
Alogliptin-d3
|
1133421-35-8
|
Setanaxib
|
2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮
|
1218942-37-0
|
Alogliptin Benzoate
|
苯甲酸阿格列汀
|
850649-62-6
|
Liproxstatin-1 HCl(free base)
|
利普司他丁-1
|
950455-15-9
|
Rogaratinib
|
罗加替尼
|
1443530-05-9
|
PD153035 hydrochloride
|
4-[(3-溴苯基)氨基]-6,7-二甲氧基喹啉
|
153436-54-5
|
AG-1478
|
AG1478
|
153436-53-4
|
Varlitinib (ARRY334543)
|
泛EGFR小分子抑制剂(VARLITINIB)
|
845272-21-1
|
AST-1306
|
AST-1306
|
897383-62-9
|
AST-1306 TsOH
|
艾力替尼
|
1050500-29-2
|
Mutant EGFR inhibitor
|
N-[5-[[5-氯-4-(1H-吲哚-3-基)-2-嘧啶基]氨基]-2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基苯基]-2-丙烯酰胺
|
1421373-62-7
|
AZD-9291 (Mesylate)
|
AZD9291(甲磺酸盐)
|
1421373-66-1
|
OSI-420 free base
|
2-[[4-[(3-乙炔基苯基)氨基]-7-(2-甲氧基乙氧基)-6-喹唑啉基]氧基]乙醇
|
183321-86-0
|
AZD3759
|
AZD3759
|
1626387-80-1
|
RG 13022
|
RG-13022
|
136831-48-6
|
Compound 56
|
N-(3-溴苯基)-6,7-二乙氧基-4-喹唑啉胺
|
171745-13-4
|
AP-III-a4
|
AP-III-A4
|
1177827-73-4
|
Golgicide A-2
|
GOLGICIDE A-2
|
1394285-50-7
|
Rupintrivir
|
(2E,4S)-4-[(2R,5S)-2-(4-氟苄基)-6-甲基-5-(5-甲基异恶唑-3-基甲酰氨基)-4-氧代庚酰氨基]-5-[[(3S)-2-氧代-3-吡咯烷基]-2-戊烯酸乙酯
|
223537-30-2
|
Pirodavir
|
吡罗达韦
|
124436-59-5
|
Antiviral agent 24
|
N6-(3-Trifluoromethylbenzyl)adenosine
|
23661-03-2
|
Pleconaril
|
普可那利
|
153168-05-9
|
ONO-AE3-208
|
4-氰基-2-[[2-(4-氟-1-萘基)-1-氧代丙基]氨基]苯基丁酸
|
402473-54-5
|
UniPR129
|
化合物 T26310
|
1639159-47-9
|
NVP-BHG712 isomer
|
NVP-BHG712 isomer
|
2245892-85-5
|
JI-101
|
JI-101
|
900573-88-8
|
123C4
|
化合物123C4
|
2034159-30-1
|
AR-9281
|
1-[(1-Acetylpiperidin-4-yl)-3-adamantan-1-yl]urea
|
913548-29-5
|
SWE101
|
SWE101
|
2376322-12-0
|
sEH inhibitor-7
|
化合物 SEH INHIBITOR-7
|
340221-20-7
|
GSK2256294A
|
SEH抑制剂(GSK2256294A)
|
1142090-23-0
|
AX-15836
|
2035509-96-5
|
2035509-96-5
|
JWG-071
|
JWG-071
|
2250323-50-1
|
Tizaterkib
|
CS-2696
|
2097416-76-5
|
BAY885
|
BAY-885
|
2307249-33-6
|
KO-947
|
KO-947
|
1695533-89-1
|
ERK1/2 inhibitor 1
|
ERK1/2 INHIBITOR 1
|
2095719-90-5
|
CC-90003
|
1621999-82-3
|
1621999-82-3
|
Rineterkib
|
ERK-IN-1 (COMPOUND B)
|
1715025-32-3
|
URB597
|
URB597
|
546141-08-6
|
BMS-962212
|
BMS-962212
|
1430114-34-3
|
Asundexian
|
ASUNDEXIAN
|
2064121-65-7
|
Darexaban
|
N-[2-羟基-6-(4-甲氧基苯甲酰氨基)苯基]-4-(4-甲基-1,4-二氮杂庚烷-1-基)苯甲酰胺
|
365462-23-3
|
Apixaban-13C,d3
|
阿哌沙班杂质13C-D3
|
1261393-15-0
|
Edoxaban tosylate
|
伊多塞班对甲苯磺酸盐
|
480449-71-6
|
DY131
|
N'-(4-(二乙氨基)亚苄基)-4-羟基苯甲酰肼
|
95167-41-2
|
Rineterkib hydrochloride
|
RINETERKIBHCL
|
1715025-34-5
|
BIX02188
|
(3Z)-3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯亚甲基]-2,3-二氢-2-氧代-1H-吲哚-6-甲酰胺
|
334949-59-6
|
FR 180204
|
FR180204
|
865362-74-9
|
ASTX029
|
ASTX-029
|
2095719-92-7
|
ERK-IN-3
|
ASN007; ASN-007; ASN 007;
|
2055597-12-9
|
DMU-212
|
3,4,5,4'-四甲氧基二苯乙烯
|
134029-62-2
|
MAP855
|
化合物 MAP855
|
1660107-77-6
|
Anti-inflammatory agent 35
|
化合物T64358
|
2293951-00-3
|
RLX-33
|
RLX-33
|
2784577-71-3
|
XMD17-109
|
XMD17 109
|
1435488-37-1
|
Ulixertinib
|
4-[5-氯-2-[(1-甲基乙基)氨基]-4-吡啶基]-N-[(1S)-1-(3-氯苯基)-2-羟基乙基]-1H-吡咯-2-甲酰胺
|
869886-67-9
|
Ravoxertinib
|
GDC-0994
|
1453848-26-4
|
LM22B-10
|
2-[[4-[[4-[BIS-(2-HYDROXYETHYL)-AMINO]-PHENYL]-(4-CHLORO-PHENYL)-METHYL]-PHENYL]-(2-HYDROXY-ETHYL)-AMINO]-ETHANOL
|
342777-54-2
|
Lidocaine hydrochloride
|
盐酸利多卡因
|
73-78-9
|
EF24
|
3,5-Bis[(2-fluorophenyl)Methylene]-4-piperidinone
|
342808-40-6
|
CK2/ERK8-IN-1
|
CK2/ERK8-IN-1
|
1085822-09-8
|
(rel)-AR234960
|
(rel)-AR234960
|
1408311-94-3
|
Lidocaine
|
利多卡因
|
137-58-6
|
VX-11e
|
VX11E
|
896720-20-0
|
Ulixertinib (hydrochloride)
|
BVD-523 盐酸盐
|
1956366-10-1
|
BMS-309403 sodium
|
BMS-309403 SODIUM
|
2802523-05-1
|